Is C-reactive protein specific for vascular disease in women?

被引:60
|
作者
Rifai, N [1 ]
Buring, JE [1 ]
Lee, IM [1 ]
Manson, JE [1 ]
Ridker, PM [1 ]
机构
[1] Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA
关键词
D O I
10.7326/0003-4819-136-7-200204020-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: C-reactive protein (CRP) predicts risk for future cardiovascular events in asymptomatic individuals. However, because CRP also predicts total mortality, its specificity for vascular disease is uncertain. Objective: To compare the predictive value of CRP for cancer and cardiovascular disease, the major determinants of mortality. Design: Prospective, nested case-control study. Setting: The Women's Health Study, an ongoing prospective cohort study involving 28345 U.S. women 45 years of age and older who were healthy at the time of enrollment. Participants: 643 women who subsequently developed cancer or had cardiovascular events; 643 age- and smoking-matched women who remained free of either disease during 58-month follow-up. Measurements: Baseline CRP levels. Results: Little evidence showed that increasing quartiles of baseline CRP predicted incident cancer (adjusted relative risks, 1.0, 1.2, 1.1, and 1.3; P for trend > 0.2). In contrast, increasing quartiles of baseline CRP were a strong marker of risk for future cardiovascular disease (adjusted relative risks, 1.0, 2.9, 3.4, and 5.6; P for trend < 0.001). \ Conclusion: C-reactive protein appears to independently predict cardiovascular events but not cancer.
引用
收藏
页码:529 / 533
页数:5
相关论文
共 50 条
  • [1] C-reactive protein and vascular disease
    Magadle, R
    Weiner, P
    Sotzkover, A
    Berar-Yanay, N
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (01): : 50 - 52
  • [2] C-reactive protein - does it promote vascular disease?
    Stenvinkel, Peter
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (10) : 2718 - 2720
  • [3] C-reactive protein measurement in the patient with vascular disease
    Widener, Jeanne M.
    [J]. JOURNAL OF VASCULAR NURSING, 2007, 25 (03) : 51 - 54
  • [4] Inflammation and vascular disease: the role of C-reactive protein
    Matthew J.Sorrentino
    Loan Pham
    Thach Nguyen
    [J]. Journal of Geriatric Cardiology, 2004, (01) : 17 - 20
  • [5] Genetically elevated C-reactive protein and ischemic vascular disease
    Zacho, Jeppe
    Tybjaerg-Hansen, Anne
    Jensen, Jan Skov
    Grande, Peer
    Sillesen, Henrik
    Nordestgaard, Borge G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (18): : 1897 - 1908
  • [6] C-reactive protein (CRP) as a marker in peripheral vascular disease
    Abdellaoui, A.
    Al-Khaffaf, H.
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2007, 34 (01) : 18 - 22
  • [7] Genetically elevated C-reactive protein and ischemic vascular disease
    James K. Liao
    [J]. Current Atherosclerosis Reports, 2009, 11 (4) : 245 - 245
  • [8] Genetically Elevated C-Reactive Protein and Vascular Disease.
    Bubb, Michael R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (09): : 933 - 934
  • [9] Erythrocyte sedimentation rate and C-reactive protein in peripheral vascular disease
    Vainas, T
    Stassen, FR
    de Graaf, R
    Twiss, EL
    Herngreen, SB
    Welten, RJ
    van den Akker, LH
    van Dieijen-Visser, MP
    Kitslaar, PJ
    [J]. CIRCULATION, 2004, 110 (17) : 373 - 373
  • [10] Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
    Ridker, Paul M.
    Danielson, Eleanor
    Fonseca, Francisco A. H.
    Genest, Jacques
    Gotto, Antonio M., Jr.
    Kastelein, John J. P.
    Koenig, Wolfgang
    Libby, Peter
    Lorenzatti, Alberto J.
    MacFadyen, Jean G.
    Nordestgaard, Borge G.
    Shepherd, James
    Willerson, James T.
    Glynn, Robert J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (21): : 2195 - 2207